Authors:
Wright, P
Birkett, M
David, SR
Meehan, K
Ferchland, I
Alaka, KJ
Saunders, JC
Krueger, J
Bradley, P
San, L
Bernardo, M
Reinstein, M
Breier, A
Citation: P. Wright et al., Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia, AM J PSYCHI, 158(7), 2001, pp. 1149-1151
Authors:
Rosel, P
Arranz, B
San, L
Vallejo, J
Crespo, JM
Urretavizcaya, M
Navarro, MA
Citation: P. Rosel et al., Altered 5-HT2A binding sites and second messenger inositol trisphosphate (IP3) levels in hippocampus but not in frontal cortex from depressed suicidevictims, PSYCH RES-N, 99(3), 2000, pp. 173-181
Authors:
Cami, J
Farre, M
Mas, M
Roset, PN
Poudevida, S
Mas, A
San, L
de la Torre, R
Citation: J. Cami et al., Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): Psychomotor performance and subjective effects, J CL PSYCH, 20(4), 2000, pp. 455-466
Authors:
Segura, D
Stramesi, C
Redon, A
Ventura, M
Sanchez, CJ
Gonzalez, G
San, L
Montagna, M
Citation: D. Segura et al., Immunological screening of drugs of abuse and gas chromatographic mass spectrometric confirmation of opiates and cocaine in hair, J CHROMAT B, 724(1), 1999, pp. 9-21
Citation: L. San, Future research directions and the impact of the MATCH project on researchtechnology in the addictions, ADDICTION, 94(1), 1999, pp. 55-57
Authors:
Rosel, P
Arranz, B
San, L
Urretavizcaya, M
Marcusson, J
Navarro, MA
Citation: P. Rosel et al., 5-HT2A receptors and their second messenger IP3 are only correlated in human brain and not in platelets., NEUROSC R C, 25(3), 1999, pp. 129-138
Authors:
Rosel, P
Arranz, B
Oros, M
Vallejo, J
San, L
Marcusson, J
Navarro, MA
Citation: P. Rosel et al., Different regional distribution of the 5-HT reuptake complex, the 5-HT2A receptors and their second messenger IP3 in human brain., NEUROSC R C, 24(2), 1999, pp. 107-115